BullishWhales · Analysts · Analyst Profile
Analyst rating accuracy & track record
Julian Harrison does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 RNACCartesian Therapeutics Inc. | Buy | $42.00 | Dec 2024 | −76.3% | Miss |
 AVTXAvalo Therapeutics Inc | Buy | $40.00 | Dec 2024 | +94.5% | Miss |
 OTLKOUTLOOK THERAPEUTICS INC | Buy | $9.00 | Nov 2024 | −15.8% | Miss |
 ACRSAclaris Therapeutics Inc | Buy | $8.00 | Nov 2024 | −46.4% | Miss |
 VYNEVyne Therapeutics Inc | Buy | $8.00 | Nov 2024 | −96.0% | Miss |
| OTLKOUTLOOK THERAPEUTICS INC | Buy | $50.00 | Oct 2024 | −71.4% | Miss |
 RZLTRezolute Inc | Buy | $15.00 | Sep 2024 | +67.6% | Miss |
| RZLTRezolute Inc | Buy | $13.00 | Jul 2024 | +33.9% | Miss |
 ABVXAbivax SA American Depositary Shares | Buy | $43.00 | May 2024 | −53.1% | Miss |
 SYRESpyre Therapeutics Inc. | Buy | $40.00 | May 2024 | −56.0% | Hit |
 TBPHTheravance Biopharma Inc | Buy | $21.00 | Apr 2024 | −13.5% | Miss |
| OTLKOUTLOOK THERAPEUTICS INC | Buy | $50.00 | Mar 2024 | −88.0% | Miss |
 AKBAAkebia Ther | Buy | $4.00 | Nov 2023 | +80.3% | Miss |
 MTNBMatinas BioPharma Holdings Inc | Buy | $3.00 | Oct 2023 | −109.2% | Hit |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.